Focus: Philips is a global leader in medical devices and healthcare technology with 10,000+ employees, headquartered in Amsterdam and publicly traded on the NYSE. The company operates across diagnostic imaging, patient monitoring, and therapeutic devices with a focus on workflow solutions and AI-enabled technologies.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Hot — 892 jobs added in 30d
Net +256 (892 new, 636 removed). Aggressive expansion phase.
Philips is a stable, device-first company best for professionals seeking commercial scale and engineering-driven careers; limited clinical pipeline appeal for those targeting drug development leadership.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Philips
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Philips's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
+1 more
Beyond chemotherapy: Loveworld powers emerging radiopharmaceutical cancer treatment - National Daily Newspaper
Beyond chemotherapy: Loveworld powers emerging radiopharmaceutical cancer treatment National Daily Newspaper
8-K Filing: BMO 2026-C15 Mortgage Trust (CIK 0002063009) — BMO 2026-C14 PSA
BMO 2026-C14 PSA
8-K Filing: DocGo Inc. (DCGO) (CIK 0001822359) — EX-2.1
EX-2.1
8-K Filing: Dream Finders Homes, Inc. (DFH) (CIK 0001825088) — 8-K
8-K
8-K Filing: Angi Inc. (ANGI) (CIK 0001705110) — 8-K
8-K
8-K Filing: TELA Bio, Inc. (TELA) (CIK 0001561921) — FORM 8-K
FORM 8-K
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo